glp 1 donald trump Novo Nordisk, Lilly strike deal with to slash weight-loss drug prices Trump low-cost GLP-1 plan a

Eli Lilly delivered a Q1 2026 trifectaearnings beat, raised full-year guidance, and early-April FDA approval of Foundayo, the first oral GLP-1 with no food or water restrictionswidening its lead over Novo Nordisk just as the race for a convenient weight-loss pill heats up

The molecule glutathione, known as the mother of all antioxidants, has been connected to several health-related advantages

& Ueda, P

Tingling without an obvious cause

Despite a few potential ocular risks caused by GLP-1RAs, more clinical studies continue to discover and confirm their beneficial role in the eye, providing hope for creating a new weapon to treat eye diseases